Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-02
1999-06-01
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31445
Patent
active
059088508
ABSTRACT:
Methods for treating Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, AIDS Dementia Complex and cognitive decline in HIV-AIDS while minimizing drug hypersensitivity, toxicity, side effects, euphoric effect, and drug abuse potential by administration of d-threo-methylphenidate or pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 2507631 (1950-05-01), Hartmann et al.
patent: 2957880 (1960-10-01), Rometsch
patent: 4992445 (1991-02-01), Lawter et al.
patent: 5104899 (1992-04-01), Young et al.
patent: 5114946 (1992-05-01), Lawter et al.
patent: 5217718 (1993-06-01), Colley et al.
patent: 5283193 (1994-02-01), Yamamoto et al.
patent: 5284769 (1994-02-01), Evans et al.
patent: 5331000 (1994-07-01), Young et al.
patent: 5362755 (1994-11-01), Barberich et al.
patent: 5375693 (1994-12-01), Woosley et al.
patent: 5449743 (1995-09-01), Kobayashi et al.
Angrist et al. Journal of Clinical Phsychopharmacology, 1992 12:268-272.
Barkley et al. Pediatrics 1990 86:184-192.
Barkley et al. Pediatrics 1991 87:519-531.
Golinko Neuro-Psychopharmacol. & Biol Phsychiat 1984 8:1-8.
Greenhill Pediatric Psychopharmacology 1992 15:1-27.
Scott Drug Safety 1993 8:149-159.
White et al. J. Clin. Phsychiatry 1992 53:153-156.
Biosis Abstract No.: 87129969 Holmes et al. Psychostimulant Response in Aids-Related Complex Patients J. Clin. Psychiatry 50(1):5-8 (1989).
Biosis Abstract No.: 95066168 Srinivas et al. Enantioselective Pharmacolinetics and Pharmacodynamics of Racemic Threo-Methylphenidate in Children with Attention Deficit Hyperactivity Disorder Clin. Pharmacol. Ther 52(2):561-568 (1990).
Bowden et al. Reactions of Carbonyl COmpounds in Basic SOlutions The Alkaline Hydrolysis of N-Methyl, N-Phenyl, and Bicyclo Lactams Penicillins, and N-Alkyl-N-methylacetamides J. Chem. Soc. Perkin Trans. 1990 12:2111-2116.
Ding et al., Cis- and trans-Axetidin-2-ones from Nitrones and Copper Acetylide J. Chem. Soc. Perkin 1976 22:2382-2386.
Brown, C. Chirality in Drug Design and Synthesis Academic Press Inc. 1990 4-7.
Klibanov A.M. Asymmetric Transformations Catalyzed by Enzymes in Organic Solvents Acc. Chem. Res. 1990 23:114-120.
Earle et al. J. Chem. Soc. 1969:2093 (1980).
Srinivas et al. Enantiomeric Gas Chromatography Assay with Electron Capture Detection for d-Ritalinic Acid in Plasma, J. Chromatagraph 1990 530:327-336.
Srinivas et al. Sterioselective Disposition of Methylphenidate in Children with Attention Deficit Disorder J. Pharmacol. Exp. Ther. 1987 241:300-306.
Corey et al. J. Amer. Chem. Soc 1965 87:2518.
Moll F. Naturforsch Teil B. 1966 21:297.
Greenhill Pediatric Psychopharmacology 1992 15:1-27.
Scott Drug Safety 1993 8:149-159.
White et al. J. Clin. Psychiatry 1992 53:153-156.
Greenhill L. Attention-Deficit Hyperactivity Disorder Child & Adol. Psych. Clin. N.A., 1995 4:123-165.
Navia et al. Annals of Neurology 1986 19:517-524.
Douzenis et al. Proc 7th. Int'l. Conf. AIDS 1991 1:2135-2215.
Aoyama et al. Pharmacolinetics and pharmacodynamics of (+)-threo-methylphenidate enantiomer in patients with hypersomnia Clin. Pharmacol. Ther 1994 55:270-276.
Uetrecht et al. Pharmacol Res. 1989 6:265-273.
Staal et al. Lancet 1992 339:909-912.
Rieder et al. Ann. Intern Med. 1989 110:286-289.
Patrick et al. J. Pharmacol & Exp. Terhap. 1987 241:152-158.
Srinivas et al. Pharmacol Res. 1993 10:14-21.
Brown G. Int'l J. Psychiatry Med. 1995 25:21-37.
Dariani Maghsoud M.
Stirling David I.
Zeitlin Andrew L.
Celgene Corporation
Henley III Raymond
LandOfFree
Method of treating attention deficit disorders with d-threo meth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating attention deficit disorders with d-threo meth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating attention deficit disorders with d-threo meth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-955114